TRIM25: A central factor in breast cancer
Ángeles C. Tecalco-Cruz, María Jazmín Abraham‐Juárez, Helena Solleiro-Villavicencio, Josué O. Ramírez‐Jarquín
Abstract
expression and its functional relevance in breast cancer progression. These studies suggest that TRIM25 may be a biomarker and a therapeutic target for breast cancer.
Topics & Concepts
MedicineBreast cancerCancerOncologyInternal medicineinterferon and immune responsesUbiquitin and proteasome pathwaysCytokine Signaling Pathways and Interactions